聯(lián)系我們
- 公司名稱(chēng)：上海聚慕醫療器械有限公司
- 電話(huà)：021-68812558
- 傳真：021-68812099
- 聯(lián)系人：金娟
- 手機:13524616695
|
產(chǎn)品展示
點(diǎn)擊放大 |
產(chǎn)品名稱(chēng)： |
Calcitonin多克隆抗體 |
| 產(chǎn)品型號： |
|
| 產(chǎn)品產(chǎn)地： |
中國大陸 |
| 訪(fǎng)問(wèn)次數： |
1586 |
| 發(fā)布時(shí)間： |
2016/3/29 15:29:21 |
Calcitonin (CT) is a 32 amino acid peptide synthesized by the parafollicular C
cells of the thyroid. |
Calcitonin多克隆抗體
Polyclonal
7 mL BOND ready-to-use PA0406 P (Enzyme)
Antigen Background
Calcitonin (CT) is a 32 amino acid peptide synthesized by the parafollicular C
cells of the thyroid. It acts through its receptors to inhibit osteoclast mediated
bone resorption, decrease calcium resorption by the kidney ａnd decrease
calcium absorption by the intestines. The action of calcitonin is therefore to
cause a reduction in serum calcium, an effect opposite to that of parathyroid
hormone. The calcitonin gene transcript also encodes the calcitonin generelated peptide (CGRP), which is thought to be a potent vasodilator. The tissue specificity of the transcript produced depends on alternative splicing of the
CT/CGRP gene transcript. In the parafollicular cells of the thyroid 95 percent
of the CT/CGRP is processed ａnd translated to produce CT, however, in
neuronal cells 99 percent of the CT/CGRP RNA is translated into CGRP. The C
cells of the thyroid give rise to an endocrine tumor, medullary thyroid
carcinoma (MTC), which occurs in a sporadic (75 percent of cases) and
hereditary form (25 percent of cases). Familial MTC is associated with C cell
hyperplasia (CCH), whereas sporadic MTC is thought not to be. However, in
the general population CCH is present in 20-30 percent of thyroid glands,
either with normal histology, thyroiditis or follicular tumors.
Medullary carcinoma: immunohistochemical staining with BOND ready-to-use Calcitonin
(Polyclonal) using BOND Polymer Refine Detection.
更新時(shí)間：2024/10/14 13:31:42
經(jīng)營(yíng)許可證號：滬寶食藥監械經(jīng)營(yíng)許20220040號
標簽：多克隆 Polyclonal 徠卡抗體
|
技術(shù)支持：阿儀網(wǎng)， (滬)-非經(jīng)營(yíng)性-2022-0060總訪(fǎng)問(wèn)量：4510148
